newsfilter
← Latest News
PR Newswire·

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biotechnology company pioneering gamma delta T cell therapies for the treatment of...